The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

Not specified

Conditions
HIV InfectionsHIV SeronegativityLipodystrophy
Interventions
DRUG

Pravastatin sodium

DRUG

Simvastatin

DRUG

Atorvastatin calcium

DRUG

Nelfinavir mesylate

DRUG

Efavirenz

Trial Locations (10)

14642

Univ of Rochester Medical Center, Rochester

15213

Univ of Pittsburgh, Pittsburgh

21287

Johns Hopkins Hosp, Baltimore

55455

Univ of Minnesota, Minneapolis

63108

Washington Univ / St Louis Connect Care, St Louis

Washington Univ School of Medicine, St Louis

80262

Univ of Colorado Health Sciences Ctr, Denver

98104

Univ of Washington, Seattle

452670405

Univ of Cincinnati, Cincinnati

943055107

Stanford Univ Med Ctr, Stanford

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH